BioSpace News Archive

NEW LATE BREAKING DATA DEMONSTRATE PENUMBRA’S COMPUTER ASSISTED VACUUM THROMBECTOMY TECHNOLOGY FOR PULMONARY EMBOLISM IMPROVED PATIENT OUTCOMES

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the latest STRIKE-PE data evaluating Penumbra’s Indigo® Aspiration System with Lightning™.

November 1, 2023
·
7 min read
Business

BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year

BioMarin Pharmaceutical Inc. announced financial results for the nine months and third quarter ended September 30, 2023.

November 1, 2023
·
26 min read
Business

Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD) and AbCellera (Nasdaq: ABCL) today announced a multi-year, multi-program partnership to discover, develop, and commercialize potentially first-in-class treatments for patients with cancer.

November 1, 2023
·
6 min read
Business

Tandem Diabetes Care Announces Third Quarter 2023 Financial Results

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, reported its financial results for the quarter ended September 30, 2023 and updated its financial guidance for the year ending December 31, 2023.

November 1, 2023
·
16 min read
argenx to Present at Upcoming November 2023 Investor Conferences

Amsterdam, the Netherlands – argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that members of management will participate in several upcoming investor conferences in November.

November 1, 2023
·
1 min read
Spexis Announces Changes to the Executive Committee

Spexis AG announced that Hernan Levett, currently Chief Financial Officer, has decided to pursue a new career opportunity outside the company.

November 1, 2023
·
2 min read
Pharm Country

Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca

Cellectis announced it has entered into a Joint Research Collaboration Agreement, an investment agreement relating to an initial equity investment of $80M, and a memorandum of understanding relating to an additional equity investment of $140M, with AstraZeneca.

November 1, 2023
·
9 min read
Business

RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors

RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, announced the appointment of Tim Van Hauwermeiren to its board of directors.

November 1, 2023
·
4 min read
NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support

NorthX Biologics AB is excited to announce the launch of its proprietary plasmids for the efficient manufacture of AAV vectors for gene therapy.

November 1, 2023
·
2 min read
Pharm Country

Sanofi launches “The 1 Pledge” movement to drive early screening for type 1 diabetes in the U.S.

Sanofi, a leader in diabetes care, launched “The 1 Pledge” movement, a nationwide education campaign urging families to get screened for type 1 diabetes so that those who will eventually be affected by the disease can begin to prepare as soon as possible.

November 1, 2023
·
9 min read